UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000002838 |
|---|---|
| Receipt number | R000003467 |
| Scientific Title | Phase 2 study of the treatment discontinuation after the change from imatinib to Interferon-alpha in chronoic myeloid leukemia patients who maintained major molecular remission. |
| Date of disclosure of the study information | 2009/12/22 |
| Last modified on | 2021/03/28 20:26:20 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2009/12/03 14:43:34 | ||
| 2 | Update | 2010/12/13 20:12:33 | Key inclusion criteria Key inclusion criteria |
|
| 3 | Update | 2011/06/09 13:07:51 | Last follow-up date |
|
| 4 | Update | 2013/06/03 13:19:28 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 5 | Update | 2013/06/03 13:20:51 | Recruitment status Publication of results |
|
| 6 | Update | 2014/06/03 10:23:09 | Email Address TEL |
|
| 7 | Update | 2014/12/03 09:18:15 | Last follow-up date |
|
| 8 | Update | 2015/07/03 19:57:43 | Email |
|
| 9 | Update | 2021/03/28 20:26:20 | Recruitment status Date of IRB |
